Alzheimer's patients continue experimental therapy in Long-Term safety study
NCT ID NCT07228078
Summary
This study continues testing an experimental treatment called SNK01 in people with Alzheimer's disease who completed an earlier trial. It aims to check the long-term safety and side effects of receiving SNK01 infusions every three weeks. Researchers will also look for any changes in memory, thinking, and daily function over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Behavioral Research Specialists, LLC
RECRUITINGGlendale, California, 91206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.